Cargando…

Balancing STAT Activity as a Therapeutic Strategy

Driven by dysregulated IL-6 family member cytokine signaling in the tumor microenvironment (TME), aberrant signal transducer and activator of transcription (STAT3) and (STAT5) activation have been identified as key contributors to tumorigenesis. Following transformation, persistent STAT3 activation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polak, Kelsey L., Chernosky, Noah M., Smigiel, Jacob M., Tamagno, Ilaria, Jackson, Mark W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895889/ https://www.ncbi.nlm.nih.gov/pubmed/31684144 http://dx.doi.org/10.3390/cancers11111716

Ejemplares similares

The Role of the Innate Immune System in Cancer Dormancy and Relapse
por: Chernosky, Noah M., et al.
Publicado: (2021)

Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem
por: Smigiel, Jacob M., et al.
Publicado: (2019)

Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
por: Smigiel, Jacob M., et al.
Publicado: (2018)

Cancer Stem Cell Plasticity Drives Therapeutic Resistance
por: Doherty, Mary R., et al.
Publicado: (2016)

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
por: Kim, Jennifer E., et al.
Publicado: (2014)

STAT1 and STAT3 in tumorigenesis: A matter of balance
por: Avalle, Lidia, et al.
Publicado: (2012)

Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
por: Junk, D J, et al.
Publicado: (2017)

STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?
por: Nguyen, Paul M., et al.
Publicado: (2015)

Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
por: Wu, Chin-Jui, et al.
Publicado: (2019)

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease
por: Tamagno, Elena, et al.
Publicado: (2021)

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2016)

The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression
por: Ahn, Ryuhjin, et al.
Publicado: (2017)

HiJAK’d Signaling; the STAT3 Paradox in Senescence and Cancer Progression
por: Junk, Damian J., et al.
Publicado: (2014)

Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases
por: Huang, Chunhui, et al.
Publicado: (2020)

The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies
por: Wang, Weiyuan, et al.
Publicado: (2023)

Targeting STAT3 in Cancer with Nucleotide Therapeutics
por: K. Lau, Yue-Ting, et al.
Publicado: (2019)

STAT3 and STAT5 Activation in Solid Cancers
por: Igelmann, Sebastian, et al.
Publicado: (2019)

Current therapeutic strategies for invasive and metastatic bladder cancer
por: Vishnu, Prakash, et al.
Publicado: (2011)

JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
por: Godoi, Mariely A., et al.
Publicado: (2023)

STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
por: Lee, Carol, et al.
Publicado: (2019)

The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
por: Ou, Alexander, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

Therapeutic Strategies to Activate p53
por: Aguilar, Angelo, et al.
Publicado: (2022)

Critical analysis of the potential for targeting STAT3 in human malignancy
por: Peyser, Noah D, et al.
Publicado: (2013)

STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
por: Able, Ashley A., et al.
Publicado: (2017)

IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation
por: You, Wei, et al.
Publicado: (2013)

STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential
por: To, Sarah Q., et al.
Publicado: (2022)

Balancing nitrate acquisition strategies in symbiotic legumes
por: Rahmat, Zainab, et al.
Publicado: (2023)

Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
por: La Manna, Sara, et al.
Publicado: (2022)

STAT3: A Promising Therapeutic Target in Multiple Myeloma
por: Chong, Phyllis S. Y., et al.
Publicado: (2019)

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018)

Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients
por: Saad, Hanan Kamel M., et al.
Publicado: (2022)

A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas
por: Parameswaran, Neetha, et al.
Publicado: (2019)

Retraction: IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation
Publicado: (2022)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Somatostatin Analogs in the Medical Management of Occult Bleeding of the Lower Digestive Tract
por: Martin-Grace, Julie, et al.
Publicado: (2015)

MYO10 drives genomic instability and inflammation in cancer
por: Mayca Pozo, Franklin, et al.
Publicado: (2021)

Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance
por: Liu, Shuya, et al.
Publicado: (2020)

Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Jiang, Xi, et al.
Publicado: (2017)

Effect of Physical Activity on Static and Dynamic Postural Balance in Women Treated for Breast Cancer: A Systematic Review
por: Bula, Aleksandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dhco7hpp6ia4fc40o9g1aio0n6